126 related articles for article (PubMed ID: 3920376)
21. Non-antibody-mediated control of parasitemia in acute experimental Chagas' disease.
Trischmann TM
J Immunol; 1983 Apr; 130(4):1953-7. PubMed ID: 6403614
[TBL] [Abstract][Full Text] [Related]
22. Passive immunization of mice against Trypanosoma cruzi using convalescent mouse serum.
McHardy N
Tropenmed Parasitol; 1977 Jun; 28(2):195-201. PubMed ID: 407684
[TBL] [Abstract][Full Text] [Related]
23. Trypanosoma cruzi proteins which are antigenic during human infections are located in defined regions of the parasite.
Souto-Padrón T; Reyes MB; Leguizamon S; Campetella OE; Frasch AC; de Souza W
Eur J Cell Biol; 1989 Dec; 50(2):272-8. PubMed ID: 2516802
[TBL] [Abstract][Full Text] [Related]
24. Trypanosoma cruzi: serum antibody reactivity to the parasite antigens in susceptible and resistant mice.
de Gaspari EN; Umezawa ES; Zingales B; Stolf AM; Colli W; Abrahamsohn IA
Mem Inst Oswaldo Cruz; 1990; 85(3):261-70. PubMed ID: 2134701
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
[TBL] [Abstract][Full Text] [Related]
26. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
[TBL] [Abstract][Full Text] [Related]
27. Measurement of cytolytic antibody in experimental Chagas' disease using a terminal radiolabelling procedure.
Powell MR; Kuhn RE
J Parasitol; 1980 Jun; 66(3):399-406. PubMed ID: 6771377
[TBL] [Abstract][Full Text] [Related]
28. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes.
Duthie MS; Cetron MS; Van Voorhis WC; Kahn SJ
Acta Trop; 2005 Mar; 93(3):317-29. PubMed ID: 15725381
[TBL] [Abstract][Full Text] [Related]
29. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
Nunes MP; Andrade RM; Lopes MF; DosReis GA
J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
[TBL] [Abstract][Full Text] [Related]
30. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
Reed SG; Brownell CE; Russo DM; Silva JS; Grabstein KH; Morrissey PJ
J Immunol; 1994 Oct; 153(7):3135-40. PubMed ID: 8089491
[TBL] [Abstract][Full Text] [Related]
31. Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection.
Giddings OK; Eickhoff CS; Smith TJ; Bryant LA; Hoft DF
Infect Immun; 2006 Oct; 74(10):5549-60. PubMed ID: 16988230
[TBL] [Abstract][Full Text] [Related]
32. Comparative studies on epimastigote and metacyclic stages of Trypanosoma cruzi. II. Selective lysis by rodent sera.
Chao D; Hsu YP; Chan CH; Chen YA
Int J Zoonoses; 1985 Dec; 12(4):323-30. PubMed ID: 3939135
[TBL] [Abstract][Full Text] [Related]
33. Analysis of antibody cross-reactivity in experimental American trypanosomiasis.
Rosfjord EC; Mikhail KS; Rowland EC; Powell MR
J Parasitol; 1990 Oct; 76(5):698-702. PubMed ID: 1698959
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients.
Zúñiga E; Montes C; Barbieri G; Gruppi A
Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014
[TBL] [Abstract][Full Text] [Related]
35. Peritoneum from Trypanosoma cruzi-infected mice is a homing site of Syndecan-1 neg plasma cells which mainly provide non-parasite-specific antibodies.
Merino MC; Montes CL; Acosta-Rodriguez EV; Bermejo DA; Amezcua-Vesely MC; Gruppi A
Int Immunol; 2010 May; 22(5):399-410. PubMed ID: 20207717
[TBL] [Abstract][Full Text] [Related]
36. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence.
Rowland E; Luo H; McCormick T
J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970
[TBL] [Abstract][Full Text] [Related]
37. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.
Krettli AU; Brener Z
J Immunol; 1982 May; 128(5):2009-12. PubMed ID: 6801127
[TBL] [Abstract][Full Text] [Related]
38. [Trypanosoma cruzi: induction of changes in the peripheral nervous system in different strains of mice].
Sanz OP; Cardoni RL; Celentano AM; Rimoldi MT; Sica RE; González Cappa SM
Rev Argent Microbiol; 1991; 23(1):30-4. PubMed ID: 1667698
[TBL] [Abstract][Full Text] [Related]
39. [Levels of anti-Gal antibodies in persons infected and non-infected with Trypanosoma cruzi. Probably induced by bacteria and by the parasite].
González J; Ramírez C; Seguel X; Gutiérrez B; Manque P; Porcile P; Neira I; Sagua H
Bol Chil Parasitol; 1995; 50(1-2):3-9. PubMed ID: 8573266
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
Saldaña A; Sousa OE
J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
